Figure 4E Raw data - Increased in vivo transduction of AAV-9 cargo in Alport podocytes

Raw dataset and analysis for Figure 4E:Figure 4: AAV9-GFP transduction in kidneys of 8, 10, 12-week-old wild type and Alport mice injected with saline or the high dose (1.65 x 1014 vg/kg). E) The quantification of GFP-positive podocytes (%) is displayed for the two phenotypes WT (left) and Alport mice (right), injected with either saline (light grey bars) or high dose of AVV9-GFP (dark grey bars) (n=2-4 mice per group and per condition). Data are presented as mean ± SEM. P value图4E对应的原始数据集及分析结果： 图4：分别向8、10、12周龄的野生型（WT）及Alport综合征小鼠体内注射生理盐水，或高剂量（1.65×10¹⁴ 载体基因组/千克体重，vg/kg）的腺相关病毒9型-绿色荧光蛋白（AAV9-GFP）后，小鼠肾脏的AAV9-GFP转导情况。 E) 本部分展示了两种表型小鼠（左侧为野生型小鼠，右侧为Alport综合征小鼠）中GFP阳性足细胞（podocytes）占比（%）的定量结果：两组小鼠分别接受生理盐水注射（浅灰色柱）与高剂量AAV9-GFP注射（深灰色柱），每组每个实验条件下的小鼠数量为2~4只。数据以平均值±标准误（SEM）的形式呈现，P值